Rigel Pharmaceuticals RIGL Revenue reserves and refund liability
Revenue reserves and refund liability at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept rigl:RevenueReservesAndRefundLiability.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's revenue reserves and refund liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's revenue reserves and refund liability?
- Rigel Pharmaceuticals (RIGL) reported revenue reserves and refund liability of $364K in Q1 2026.
- How has Rigel Pharmaceuticals's revenue reserves and refund liability changed year-over-year?
- Rigel Pharmaceuticals's revenue reserves and refund liability decreased by 75.7% year-over-year, from $1.5M to $364K.
- What is the long-term trend for Rigel Pharmaceuticals's revenue reserves and refund liability?
- Over 2 years (2021 to 2024), Rigel Pharmaceuticals's revenue reserves and refund liability has grown at a 141.1% compound annual growth rate (CAGR), from $1.85M to $10.76M.
- What does revenue reserves and refund liability mean?
- Measures the change in provisions for potential product returns, rebates, or other revenue-related adjustments that reduce gross revenue. This metric reflects management's estimate of future claims against recognized sales, often influenced by contractual obligations or historical return patterns. It is critical for assessing the quality of reported revenue and potential future cash outflows.